🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our new publication consists of a review of the current and potential use of voice-based technologies in cardiovascular care and clinical trials. Link: europepmc.org/article/med/34… Pishoy Gouda Elie Ganni Varinder Kaur Randhawa Guillaume Marquis-Gravel Robert Avram Justin Ezekowitz #Research

This publication looks at therapeutic hesitancy in initiating SGLT2-i and GLP-1 agonists for treatment of heart failure. Discover how a multi-faceted approach with technology can help motivate change: journals.lww.com/co-cardiology/… Haya Aziz Elizabeth Swiggum, MD Shelley Zieroth McGill University

Our review looking at current and potential use of voice-based technologies in cardiovascular care and clinical trials is now available on Medium. dreamcvlab.medium.com/voice-based-as… Pishoy Gouda Varinder Kaur Randhawa Guillaume Marquis-Gravel Robert Avram Justin Ezekowitz McGill University Research Institute of the MUHC (The Institute) Centre universitaire de santé McGill

RAASi therapy is often prescribed to patients with cardiovascular disease, who are more at risk of severe COVID-19. When hospitalized for COVID-19, is it best to continue or discontinue RAASi? Find out in this new paper by Dr. Abhinav Sharma. Research Institute of the MUHC (The Institute) bit.ly/3gGo5K2

We are working together to innovate diabetes care in Quebec. Our new partnership with health industry leaders aims to better diagnose #type2diabetes with AI-powered tech. DREAM-CV LAB Centre universitaire de santé McGill Fondation CUSM / MUHC Foundation MEDTEQ+ #HOPTech #DECIDECV Learn more: bit.ly/3jPU7F9

Learn more about the #DECIDECV program, a new innovative project using AI to improve #T2D care in Quebec: bit.ly/37DrTe7 DREAM-CV LAB Centre universitaire de santé McGill Fondation CUSM / MUHC Foundation MEDTEQ+ HOP Tech

Renseignez-vous au sujet du programme #DECIDECV, un nouveau projet novateur optimisant l’IA pour améliorer les soins du #DT2 au Québec : bit.ly/3v1Uwul DREAM-CV LAB Centre universitaire de santé McGill Fondation CUSM / MUHC Foundation MEDTEQ+ HOP Tech

Dr. Abhinav Sharma joins Elias Makos on CJAD 800 Montreal to discuss how artificial intelligence & machine learning are helping advance DECIDE-CV. An innovative partnership with Hop Tech, Boehringer Ingelheim, Centre universitaire de santé McGill, DREAM-CV LAB & MEDTEQ+. Learn more: bit.ly/39U81nY

🎧8 min to learn more about the DECIDE-CV program. A multi-disciplinary and collaborative project aimed at using #ArtificialIntelligence-based technologies to improve health outcomes for patients with type 2 #diabetes mellitus 👏Hop Tech Boehringer Ingelheim Fondation CUSM / MUHC Foundation DREAM-CV LAB

Plus tôt cette année, Abhinav Sharma, cardiologue et chercheur à l'IR-CUSM, a lancé le projet #DecideCV de détection précoce du diabète de type 2 à l’aide d’un bracelet connecté... lapresse.ca/actualites/sci… DREAM-CV LAB Centre universitaire de santé McGill Fondation CUSM / MUHC Foundation MEDTEQ+

Découvrez le projet fascinant, DREAM-CV LAB et l’association de HOP Tech avec le Dr Abhinav Sharma, un chercheur du Centre universitaire de santé McGill et Research Institute of the MUHC (The Institute) pour aider à prévenir le diabète de type 2 grâce à l’intelligence artificielle. Pour lire la suite La Presse : bit.ly/3haA5Ye

Very powerful message by Marc Bains at the #HFupdate2023 congress! Increased education about the new evidence-based therapies and recent innovations to better diagnose and treat heart failure is key to improve patient's outcomes and quality of life!#HeartLifeCanada CHFS

Dr. Abhinav Sharma, Principle Investigator of Dream-CV Lab presenting an interactive case study at the symposium " The Importance of sequencing GDMT" as part of of #HFUpdate congress 2023.

It’s day 2️⃣! We are #excited for another day of congress filled with science, discussions, clinical pearls, #HFA millionaire quiz 🏆 and lots of opportunities to meet old and new friends! ✨ Abhinav Sharma highlights why he is excited to be at #HeartFailure2023 #HFAMotions

Dr. Sharma presenting on time to statistical benefits in the CANVAS program and CREDENCE trial at the ESC-HFA Congress in Prague. Overall, statistical benefit shows up within 45 days for heart failure outcomes. #HeartFailure2023 European Society of Cardiology

Come, join our team!

Congratulations to Postdoctoral Fellow Orhun Kose for receiving the CHF alliance fellowship award. Thanks CHF alliance for the financial support. rimuhc.ca/en/-/ri-muhc-t…

Congratulations to RI-MUHC trainee Orhun Kose, who has won the CHF Alliance Trainee Award with work that will help patients with heart failure and other cardiometabolic diseases → tinyurl.com/3z5tuawh

Looking for a postdoctoral position and interested in evaluating the use of digital health technologies in patients with cardiovascular disease? Do you have a background in computer science or bioengineering? Details in the next post

We are hiring! Postdoctoral, PhD, and Masters positions available.